Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
IDBI Healthcare Fund Direct Growth
Equity
Sectoral-Pharma
High Risk
+13.65%
3Y annualised
+0.55% 1D
NAV: 28 Jul '23
₹20.26
Min. SIP amount
Not Supported
Fund size
₹83.12 Cr
Expense ratio
1.22%
Holdings (20)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 16.03% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 10.66% |
| Cipla Ltd. | Healthcare | Equity | 8.90% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 8.86% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 8.64% |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 6.54% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 5.48% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 4.21% |
| Abbott India Ltd. | Healthcare | Equity | 4.08% |
| Syngene International Ltd. | Healthcare | Equity | 3.73% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 3.44% |
| Zydus Lifesciences Ltd. | Healthcare | Equity | 2.75% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 2.62% |
| Laurus Labs Ltd. | Healthcare | Equity | 2.40% |
| Vinati Organics Ltd. | Chemicals | Equity | 2.26% |
| Pfizer Ltd. | Healthcare | Equity | 1.82% |
| Jubilant Ingrevia Ltd. | Chemicals | Equity | 1.70% |
| Gland Pharma Ltd. | Healthcare | Equity | 1.33% |
| Indoco Remedies Ltd. | Healthcare | Equity | 1.21% |
| Natco Pharma Ltd. | Healthcare | Equity | 1.19% |
See All
Minimum investments
Min. for 1st investment
Not Supported
Min. for 2nd investment
Not Supported
Min. for SIP
Not Supported
Returns and rankings
Annualised returns
Absolute returns
| Name | 6M | 1Y | 3Y | All |
|---|---|---|---|---|
| Fund returns | +15.9% | +13.6% | +13.7% | +17.3% |
| Category average (Equity Sectoral-Pharma) | +0.2% | -2.1% | +22.1% | -- |
| Rank (Equity Sectoral-Pharma) | -- | 16 | 9 | -- |
Exit load, stamp duty and tax
Exit load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Check past data
Fund management
KDKaran DoshiJul 2023 - PresentView details
KD
Karan Doshi
Jul 2023 - Present
View details
About IDBI Healthcare Fund Direct Growth
IDBI Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by IDBI Mutual Fund. This scheme was made available to investors on 29 Mar 2010. Karan Doshi is the Current Fund Manager of IDBI Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹3,592 Cr and the Latest NAV as of 28 Jul 2023 is ₹20.26.
The IDBI Healthcare Fund Direct Growth is rated High risk. Minimum SIP Investment is set to ₹500. Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
;
Investment Objective
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)#29 in India
Total AUM₹3,591.62 Cr
Date of Incorporation29 Mar 2010
Launch Date29 Mar 2010
Address4th Floor, IDBI Tower,WTC Complex, Cuffe Parade,Colaba, Mumbai 400005
CustodianSBI SG Global Securities Services Pvt.Ltd.
Registrar & Transfer AgentKFin Tech
Email[email protected]
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,